Noreen Griffin

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Orlando, FL
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Noreen Griffin
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Noreen Griffin

Form 4 holding Member of 10% owner group, 10%+ Owner

Immune Therapeutics, Inc.

Security class
Convertible Note
Shares / value
49,772
Estimated value
Report date
28 May 2021
Price
Ownership
By: Global Reverb Corporation
Underlying class
Common Stock
Underlying amount
Form 4 holding Member of 10% owner group, 10%+ Owner

Immune Therapeutics, Inc.

Security class
Warrants (Right to Buy)
Shares / value
7,420
Estimated value
Report date
28 May 2021
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Member of 10% owner group, 10%+ Owner

Immune Therapeutics, Inc.

Security class
Common Stock
Shares / value
2,685
Estimated value
Report date
28 May 2021
Price
Ownership
By: Griffin Family Trust
Form 4 holding Member of 10% owner group, 10%+ Owner

Immune Therapeutics, Inc.

Security class
Common Stock
Shares / value
704
Estimated value
Report date
28 May 2021
Price
Ownership
By: Griffin Enterprises Group, Inc.
Form 4 holding Member of 10% owner group, 10%+ Owner

Immune Therapeutics, Inc.

Security class
Common Stock
Shares / value
429
Estimated value
Report date
28 May 2021
Price
Ownership
Direct

Insider Reports Filed by Noreen Griffin

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .